Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
5-methoxy-dimethyltryptamine dry-powder intranasal (BPL-003) / Beckley Psytech
2022-003743-10: Study to Evaluate the Efficacy and Safety of Intranasal BPL-003 in Patients with Treatment Resistant Depression	Not yet recruiting	2	225	Europe	5-MeO-DMT.Benzoate Dry Powder, BPL-003, Nasal powder in single-dose container	Beckley Psytech Ltd., Beckley Psytech Ltd.	Treatment-Resistant Depression (TRD), Depression that has not improved with other treatments., Psychiatry and Psychology [F] - Mental Disorders [F03]
NCT05660642: An Open-Label, Single Dose Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression	Recruiting	2	52	Europe	BPL-003	Beckley Psytech Limited	Treatment Resistant Depression	11/24	11/24
NCT05674929: An Open-Label, Single Dose Study in Patients With Alcohol Use Disorder	Recruiting	2	12	Europe	BPL-003	Beckley Psytech Limited	Alcohol Use Disorder	10/24	10/24
NCT05870540: BPL-003 Efficacy and Safety in Treatment Resistant Depression	Recruiting	2	225	Europe, US, RoW	BPL-003	Beckley Psytech Limited	Treatment Resistant Depression	10/24	12/24
NCT05347849: Single Ascending Dose Study With BPL-003 in Healthy Subjects	Completed	1	62	Europe	BPL-003, Placebo	Beckley Psytech Limited	Pharmacokinetics in Healthy Adults	01/24	01/24